By M&A — Skye Bioscience Acquires Redx Pharma, Exits Obesity for Fibrosis Focus The Clinical Trial Vanguard
Auto-published by the finit.news Events monitor from M&A; summarized by AI and may contain errors — verify against the primary source. August 16, 2026.